First Time Loading...

BioNTech SE
NASDAQ:BNTX

Watchlist Manager
BioNTech SE Logo
BioNTech SE
NASDAQ:BNTX
Watchlist
Price: 92.2 USD -0.09% Market Closed
Updated: May 16, 2024

BioNTech SE
Operating Income

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

BioNTech SE
Operating Income Peer Comparison

Comparables:
MOR
CVAC
IMTX
BIO
FYB

Competitive Operating Income Analysis
Latest Figures & CAGR of Competitors

Company Operating Income CAGR 3Y CAGR 5Y CAGR 10Y
BioNTech SE
NASDAQ:BNTX
Operating Income
€908m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
MorphoSys AG
XETRA:MOR
Operating Income
-€440.4m
CAGR 3-Years
-30%
CAGR 5-Years
-58%
CAGR 10-Years
N/A
CureVac NV
NASDAQ:CVAC
Operating Income
-€269.7m
CAGR 3-Years
-35%
CAGR 5-Years
-30%
CAGR 10-Years
N/A
Immatics NV
NASDAQ:IMTX
Operating Income
-€101.7m
CAGR 3-Years
-13%
CAGR 5-Years
-24%
CAGR 10-Years
N/A
Biotest AG
XETRA:BIO
Operating Income
€120.3m
CAGR 3-Years
N/A
CAGR 5-Years
57%
CAGR 10-Years
8%
Formycon AG
XETRA:FYB
Operating Income
-€369k
CAGR 3-Years
62%
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is BioNTech SE's Operating Income?
Operating Income
908m EUR

Based on the financial report for Dec 31, 2023, BioNTech SE's Operating Income amounts to 908m EUR.

What is BioNTech SE's Operating Income growth rate?
Operating Income CAGR 1Y
-93%

Over the last year, the Operating Income growth was -93%.